Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
$1.49
-5.1%
$1.81
$0.87
$4.92
$76.89M1.58368,288 shs264,217 shs
Spectral AI, Inc. stock logo
MDAI
Spectral AI
$2.81
+4.9%
$1.98
$0.82
$3.25
$67.85M0.9890,823 shs557,924 shs
NeurAxis, Inc. stock logo
NRXS
NeurAxis
$2.46
-0.8%
$2.56
$1.33
$6.20
$17.75M3.09423,531 shs90,716 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$4.20
-2.8%
$4.71
$4.01
$9.33
$71.04M1.29188,889 shs38,140 shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-5.10%-0.67%-27.67%+34.23%-66.89%
Spectral AI, Inc. stock logo
MDAI
Spectral AI
+4.85%-1.06%+42.64%+132.23%+51.89%
NeurAxis, Inc. stock logo
NRXS
NeurAxis
-0.81%-0.40%+7.42%+51.85%-18.27%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
-2.78%-8.89%-12.68%-11.02%-30.35%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
2.2591 of 5 stars
3.53.00.00.02.20.00.0
Spectral AI, Inc. stock logo
MDAI
Spectral AI
3.5338 of 5 stars
3.75.00.00.02.73.30.0
NeurAxis, Inc. stock logo
NRXS
NeurAxis
2.6644 of 5 stars
3.55.00.00.00.03.30.0
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
1.0599 of 5 stars
3.50.00.00.02.20.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
3.00
Buy$11.00638.26% Upside
Spectral AI, Inc. stock logo
MDAI
Spectral AI
3.33
Buy$4.7569.04% Upside
NeurAxis, Inc. stock logo
NRXS
NeurAxis
3.00
Buy$7.00184.55% Upside
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.00
Buy$11.67177.78% Upside

Current Analyst Ratings Breakdown

Latest NRXS, SRTS, GUTS, and MDAI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/16/2025
NeurAxis, Inc. stock logo
NRXS
NeurAxis
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
6/16/2025
NeurAxis, Inc. stock logo
NRXS
NeurAxis
Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy$7.00
5/19/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $10.00
(Data available from 7/16/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
$60K1,216.26N/AN/A$0.59 per share2.53
Spectral AI, Inc. stock logo
MDAI
Spectral AI
$29.96M2.37N/AN/A($0.32) per share-8.78
NeurAxis, Inc. stock logo
NRXS
NeurAxis
$2.93M6.05N/AN/A($0.27) per share-9.11
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$41.81M1.65$0.42 per share10.00$3.41 per share1.23
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$68.69M-$1.85N/AN/AN/A-73,864.52%-228.66%-76.74%8/13/2025 (Estimated)
Spectral AI, Inc. stock logo
MDAI
Spectral AI
-$15.31M-$0.54N/AN/AN/A-30.75%N/A-11.37%N/A
NeurAxis, Inc. stock logo
NRXS
NeurAxis
-$14.63M-$1.19N/AN/A-492.76%N/A-641.25%8/8/2025 (Estimated)
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M$0.1042.0018.26N/A4.56%3.34%3.00%8/6/2025 (Estimated)

Latest NRXS, SRTS, GUTS, and MDAI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$0.37N/AN/AN/AN/AN/A
5/15/2025Q1 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.04-$0.16-$0.20-$0.16$7.23 million$8.34 million
5/13/2025Q1 2025
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$0.49-$0.49N/A-$0.49N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
N/AN/AN/AN/AN/A
Spectral AI, Inc. stock logo
MDAI
Spectral AI
N/AN/AN/AN/AN/A
NeurAxis, Inc. stock logo
NRXS
NeurAxis
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
4.61
2.50
2.50
Spectral AI, Inc. stock logo
MDAI
Spectral AI
N/A
1.41
1.37
NeurAxis, Inc. stock logo
NRXS
NeurAxis
N/A
0.24
0.23
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.06
5.74

Institutional Ownership

CompanyInstitutional Ownership
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
N/A
Spectral AI, Inc. stock logo
MDAI
Spectral AI
67.08%
NeurAxis, Inc. stock logo
NRXS
NeurAxis
11.77%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
N/A
Spectral AI, Inc. stock logo
MDAI
Spectral AI
30.70%
NeurAxis, Inc. stock logo
NRXS
NeurAxis
26.40%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
10248.98 millionN/AN/A
Spectral AI, Inc. stock logo
MDAI
Spectral AI
8325.32 million17.55 millionNot Optionable
NeurAxis, Inc. stock logo
NRXS
NeurAxis
197.22 million6.09 millionNot Optionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.44 million14.98 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Fractyl Health stock logo

Fractyl Health NASDAQ:GUTS

$1.49 -0.08 (-5.10%)
Closing price 07/15/2025 04:00 PM Eastern
Extended Trading
$1.60 +0.11 (+7.65%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

Spectral AI stock logo

Spectral AI NASDAQ:MDAI

$2.81 +0.13 (+4.85%)
Closing price 07/15/2025 04:00 PM Eastern
Extended Trading
$2.84 +0.04 (+1.25%)
As of 04:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.

NeurAxis stock logo

NeurAxis NASDAQ:NRXS

$2.46 -0.02 (-0.81%)
Closing price 07/15/2025 04:00 PM Eastern
Extended Trading
$2.49 +0.03 (+1.18%)
As of 07/15/2025 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$4.20 -0.12 (-2.78%)
Closing price 07/15/2025 04:00 PM Eastern
Extended Trading
$4.32 +0.12 (+2.74%)
As of 07/15/2025 05:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.